Founded in 2018, the German firm offers a suite of solutions to assist radiologists with interpreting MR images of the brain, prostate and knees. 

Docs at the AMA’s Interim Meeting in Orlando, Florida, have voted to support greater oversight of nonprofit hospitals and to standardize charity care policies.  

Under the “strategic collaboration,” subsidiary DeepHealth and GE will develop solutions that harness AI to address key challenges in radiology. 

Pylarify is a PSMA-targeted PET agent for pinpointing suspected metastasis or recurrence of prostate cancer, which will be impacted by a new Medicare policy change.  

Meanwhile, MRI and CT volumes both increased nearly 10% in Q3 when compared to the same period in 2023, the Los Angeles-based company reported.

Researchers with the University of California, Davis, detailed their randomized clinical trial in JAMA Network Open Wednesday. 

The Italy-based company is working to erect a new facility in Switzerland focused on its contrast-enhanced ultrasound products. 

This marks a rare victory for the Biden administration and federal agencies seeking to uphold provisions of the No Surprises Act.